These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35758522)

  • 1. Post-transplant mortality and graft failure after induction immunosuppression among Black heart transplant recipients in the United States.
    Salia S; Mostofsky E; Gupta S; Lehman L; Barrera FJ; Liou L; Motiwala SR; Mittleman MA
    Am J Transplant; 2022 Nov; 22(11):2586-2597. PubMed ID: 35758522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients.
    Jennings DL; Baker WL
    Pharmacotherapy; 2023 Feb; 43(2):115-121. PubMed ID: 36588475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.
    Kucirka LM; Durand CM; Bae S; Avery RK; Locke JE; Orandi BJ; McAdams-DeMarco M; Grams ME; Segev DL
    Am J Transplant; 2016 Aug; 16(8):2368-76. PubMed ID: 27111897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function.
    Ravindra KV; Sanoff S; Vikraman D; Zaaroura A; Nanavati A; Sudan D; Irish W
    Am J Transplant; 2019 Mar; 19(3):781-789. PubMed ID: 30171800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction.
    Carlo WF; Padilla LA; Xu W; Carboni MP; Kleinmahon JA; Sparks JP; Rudraraju R; Villa CR; Singh TP
    J Heart Lung Transplant; 2022 Dec; 41(12):1773-1780. PubMed ID: 36241468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns in arteriovenous fistula ligation among kidney transplant recipients in the United States Renal Data Systems.
    Hicks CW; Bae S; Pozo ME; DiBrito SR; Abularrage CJ; Segev DL; Garonzik-Wang J; Reifsnyder T
    J Vasc Surg; 2019 Sep; 70(3):842-852.e1. PubMed ID: 30853386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.
    Gralla J; Le CN; Cooper JE; Wiseman AC
    Clin Transplant; 2014 Mar; 28(3):292-8. PubMed ID: 24476453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.
    Holscher CM; Luo X; Massie AB; Purnell TS; Garonzik Wang JM; Bae S; Henderson ML; Al Ammary F; Ottman SE; Segev DL
    Am J Transplant; 2019 Jan; 19(1):269-276. PubMed ID: 30253051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient race modifies the association between obesity and long-term graft outcomes after kidney transplantation.
    Jarrar F; Tennankore K; Vinson A
    Am J Transplant; 2023 Aug; 23(8):1159-1170. PubMed ID: 37119856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Benefits of Antibody Induction by Kidney Allograft Type.
    Williams AM; Barrett M; Smith AR; Kathawate RG; Woodside KJ; Sung RS
    J Surg Res; 2020 Apr; 248():69-81. PubMed ID: 31865161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era.
    Amin AA; Araj FG; Ariyamuthu VK; Drazner MH; Ayvaci MUS; Mammen PPA; Mete M; Urey MA; Tanriover B
    Clin Transplant; 2019 Aug; 33(8):e13651. PubMed ID: 31230375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL
    Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
    Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation.
    Weeks SR; Luo X; Toman L; Gurakar AO; Naqvi FF; Alqahtani SA; Philosophe B; Cameron AM; Desai NM; Ottmann SE; Segev DL; Garonzik-Wang J
    Clin Transplant; 2020 Oct; 34(10):e14036. PubMed ID: 32652700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.